Skip to main content
Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
5.36
+0.09 (1.71%)
Nov 20, 2024, 4:00 PM EST - Market closed

Voyager Therapeutics Revenue

Voyager Therapeutics had revenue of $24.63M in the quarter ending September 30, 2024, with 433.79% growth. This brings the company's revenue in the last twelve months to $163.78M, up 3.40% year-over-year. In the year 2023, Voyager Therapeutics had annual revenue of $250.01M with 511.16% growth.

Revenue (ttm)
$163.78M
Revenue Growth
+3.40%
P/S Ratio
1.82
Revenue / Employee
$1,011,012
Employees
162
Market Cap
292.79M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023250.01M209.10M511.16%
Dec 31, 202240.91M3.49M9.33%
Dec 31, 202137.42M-133.71M-78.14%
Dec 31, 2020171.13M66.74M63.93%
Dec 31, 2019104.39M96.77M1,270.14%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 441.03M
OraSure Technologies 224.26M
Vanda Pharmaceuticals 190.86M
iTeos Therapeutics 35.00M
C4 Therapeutics 33.67M
uniQure 28.59M
Atai Life Sciences 331.00K
Revenue Rankings

VYGR News

More News